Anpac Bio Medical Probability of Future Stock Price Finishing Over 4.85

ANPCDelisted Stock  USD 4.37  0.20  4.38%   
Anpac Bio's future price is the expected price of Anpac Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Anpac Bio Medical performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
  
Please specify Anpac Bio's target price for which you would like Anpac Bio odds to be computed.

Anpac Bio Target Price Odds to finish over 4.85

The tendency of Anpac Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 4.85  or more in 90 days
 4.37 90 days 4.85 
about 79.88
Based on a normal probability distribution, the odds of Anpac Bio to move over $ 4.85  or more in 90 days from now is about 79.88 (This Anpac Bio Medical probability density function shows the probability of Anpac Stock to fall within a particular range of prices over 90 days) . Probability of Anpac Bio Medical price to stay between its current price of $ 4.37  and $ 4.85  at the end of the 90-day period is about 6.91 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.89 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Anpac Bio will likely underperform. Additionally Anpac Bio Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Anpac Bio Price Density   
       Price  

Predictive Modules for Anpac Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anpac Bio Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
4.374.374.37
Details
Intrinsic
Valuation
LowRealHigh
4.154.154.81
Details
Naive
Forecast
LowNextHigh
3.373.373.37
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.065.066.06
Details

Anpac Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Anpac Bio is not an exception. The market had few large corrections towards the Anpac Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Anpac Bio Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Anpac Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.24
β
Beta against Dow Jones1.89
σ
Overall volatility
1.72
Ir
Information ratio -0.15

Anpac Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Anpac Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Anpac Bio Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Anpac Bio Medical is not yet fully synchronised with the market data
Anpac Bio Medical has a very high chance of going through financial distress in the upcoming years
Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 12.04 M. Net Loss for the year was (103.6 M) with profit before overhead, payroll, taxes, and interest of 12.25 M.
Anpac Bio Medical currently holds about 462 K in cash with (55.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.

Anpac Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Anpac Stock often depends not only on the future outlook of the current and potential Anpac Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anpac Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.9 M
Cash And Short Term Investments1.9 M

Anpac Bio Technical Analysis

Anpac Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Anpac Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Anpac Bio Medical. In general, you should focus on analyzing Anpac Stock price patterns and their correlations with different microeconomic environments and drivers.

Anpac Bio Predictive Forecast Models

Anpac Bio's time-series forecasting models is one of many Anpac Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Anpac Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Anpac Bio Medical

Checking the ongoing alerts about Anpac Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Anpac Bio Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Anpac Bio Medical is not yet fully synchronised with the market data
Anpac Bio Medical has a very high chance of going through financial distress in the upcoming years
Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 12.04 M. Net Loss for the year was (103.6 M) with profit before overhead, payroll, taxes, and interest of 12.25 M.
Anpac Bio Medical currently holds about 462 K in cash with (55.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Anpac Stock

If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated